Your browser doesn't support javascript.
loading
Genome-wide association study of the TP53 R249S mutation in hepatocellular carcinoma with aflatoxin B1 exposure and infection with hepatitis B virus.
Han, Chuangye; Yu, Tingdong; Qin, Wei; Liao, Xiwen; Huang, Jianlu; Liu, Zhengtao; Yu, Long; Liu, Xiaoguang; Chen, Zhiwei; Yang, Chengkun; Wang, Xiangkun; Mo, Shutian; Zhu, Guangzhi; Su, Hao; Li, Jiaquan; Qin, Xue; Gui, Ying; Mo, Zengnan; Li, Lequn; Peng, Tao.
Afiliação
  • Han C; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Yu T; School of Basic Medical Sciences, Guangxi Medical University, Nanning, China.
  • Qin W; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Liao X; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Huang J; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Liu Z; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Yu L; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Liu X; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Chen Z; Department of Hepatobiliary Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Yang C; Department of General Surgery, Northern Jiangsu People's Hospital, Yangzhou, China.
  • Wang X; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Mo S; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Zhu G; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Su H; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Li J; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Qin X; Medical Scientific Research Center, Guangxi Medical University, Nanning, China.
  • Gui Y; Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Mo Z; Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Li L; Center for Genomics and Personalized Medicine, Guangxi Medical University, Nanning, China.
  • Peng T; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
J Gastrointest Oncol ; 11(6): 1333-1349, 2020 Dec.
Article em En | MEDLINE | ID: mdl-33457005
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Gastrointest Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Gastrointest Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China